Table 1 Prevalence (%) observed in the 2014 HIVCOMB study and estimates of prevalence (%) and incidence (per 100 PY) from the ‘best fit’ model (based on GOF) after completing model calibration
Observed prevalence (95% CI) in 2014 | Prevalence (95% CI) best fit model in 2014 | Incidence (per 100 PY) best fit model in 2014 | ||||
|---|---|---|---|---|---|---|
Total | 18.13 (15.35–20.91) | 17.65 (16.48–18.85) | 2.69 | |||
Risk group | Male | Female | Male | Female | Male | Female |
Low risk | 11.74 (8.30–16.35) | 20.89 (16.77–25.70) | 13.76 (12.05–15.60) | 19.72 (17.86–21.65) | 1.67 | 2.55 |
Medium risk | 20.83 (11.73–34.26) | 33.33 (15.18–58.29) | 20.87 (15.91–26.44) | 33.51 (21.52–48.27) | 2.50 | 4.57 |
High risk | 14.29 (8.17–23.80) | 36.11 (22.48–52.43) | 13.84 (10.67–17.74) | 36.64 (27.97–46.62) | 1.50 | 5.02 |